Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer.

Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer.

Undoubtedly ovarian cancer is a vexing, incurable disease for patients with recurrent cancer and therapeutic options are limited. Although the polycomb group gene, Bmi-1 that regulates the self-renewal of normal stem and progenitor cells has been implicated in the pathogenesis of many human malignan...

Full description

Bibliographic Details
Main Authors: Enfeng Wang, Sanjib Bhattacharyya, Annamaria Szabolcs, Cristian Rodriguez-Aguayo, Nicholas B Jennings, Gabriel Lopez-Berestein, Priyabrata Mukherjee, Anil K Sood, Resham Bhattacharya
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-03-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3061867?pdf=render

Internet

http://europepmc.org/articles/PMC3061867?pdf=render

Similar Items